Safety Study in Adolescent and Adult Patients With Asthma
Public ClinicalTrials.gov record NCT01476904. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 3-month Safety Evaluation Extension to the 12-week E004-C Study in Asthma Patients (A Double Blinded, Placebo-controlled, Parallel, 3-month Safety Study in Adolescent and Adult Patients With Asthma)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
E004-C2 is a continuation of E004-C for safety evaluations with additional 3 months to be able to assess the 6-month safety profile for E004 (epinephrine inhalation) versus placebo in a double-blinded manner.
Study identification
- NCT ID
- NCT01476904
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 208 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2011
- Primary completion
- Mar 31, 2012
- Completion
- Jun 30, 2012
- Last update posted
- Feb 12, 2017
2011 – 2012
United States locations
- U.S. sites
- 27
- U.S. states
- 16
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Amphastar Site 0006 | Costa Mesa | California | 92626 | — |
| Amphastar Site 0005 | Los Angeles | California | 90048 | — |
| Amphastar Site 0004 | Orange | California | 92868 | — |
| Amphastar Site 0001 | San Jose | California | 95117 | — |
| Amphastar Site 0003 | Stockton | California | 95207 | — |
| Amphastar Site 0008 | Denver | Colorado | 80230 | — |
| Amphastar Site 0009 | Wheat Ridge | Colorado | 80033 | — |
| Amphastar Site 0011 | Iowa City | Iowa | 52240 | — |
| Amphastar Site 0013 | North Dartmouth | Massachusetts | 02747 | — |
| Amphastar Site 0014 | Minneapolis | Minnesota | 55402 | — |
| Amphastar Site 0015 | Plymouth | Minnesota | 55441 | — |
| Amphastar Site 0016 | St Louis | Missouri | 63141 | — |
| Amphastar Site 0017 | Bozeman | Montana | 59718 | — |
| Amphastar Site 0019 | Bellevue | Nebraska | 68123 | — |
| Amphastar Site 0020 | Skillman | New Jersey | 08558 | — |
| Amphastar Site 0018 | Raleigh | North Carolina | 27607 | — |
| Amphastar Site 0021 | Cincinnati | Ohio | 45242 | — |
| Amphastar Site 0024 | Ashland | Oregon | 97520 | — |
| Amphastar Site 0022 | Eugene | Oregon | 97401 | — |
| Amphastar Site 0023 | Lake Oswego | Oregon | 97035 | — |
| Amphastar Site 0025 | Medford | Oregon | 97504 | — |
| Amphastar Site 0026 | Portland | Oregon | 97202 | — |
| Amphastar Site 0029 | North Charleston | South Carolina | 29406 | — |
| Amphastar Site 0031 | El Paso | Texas | 79903 | — |
| Amphastar Site 0030 | New Braunfels | Texas | 78130 | — |
| Amphastar Site 0033 | Richmond | Virginia | 23229 | — |
| Amphastar Site 0034 | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01476904, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 12, 2017 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01476904 live on ClinicalTrials.gov.